182 related articles for article (PubMed ID: 29037662)
21. Antagonism of phosphoramidon-induced antinociception in mice by mu- but not kappa-opioid receptor blockers.
Pruhs RJ; Peña RT; Quock RM
Life Sci; 2007 Apr; 80(19):1816-20. PubMed ID: 17379253
[TBL] [Abstract][Full Text] [Related]
22. Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.
Tejeda HA; Counotte DS; Oh E; Ramamoorthy S; Schultz-Kuszak KN; Bäckman CM; Chefer V; O'Donnell P; Shippenberg TS
Neuropsychopharmacology; 2013 Aug; 38(9):1770-9. PubMed ID: 23542927
[TBL] [Abstract][Full Text] [Related]
23. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
24. Stress, κ manipulations, and aversive effects of ethanol in adolescent and adult male rats.
Anderson RI; Agoglia AE; Morales M; Varlinskaya EI; Spear LP
Neuroscience; 2013 Sep; 249():214-22. PubMed ID: 23276674
[TBL] [Abstract][Full Text] [Related]
25. The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.
Laman-Maharg AR; Copeland T; Sanchez EO; Campi KL; Trainor BC
Behav Brain Res; 2017 Aug; 332():299-307. PubMed ID: 28625549
[TBL] [Abstract][Full Text] [Related]
26. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
Ko MC; Johnson MD; Butelman ER; Willmont KJ; Mosberg HI; Woods JH
J Pharmacol Exp Ther; 1999 Dec; 291(3):1113-20. PubMed ID: 10565831
[TBL] [Abstract][Full Text] [Related]
27. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
Takemori AE; Schwartz MM; Portoghese PS
J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
[TBL] [Abstract][Full Text] [Related]
28. Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism.
Al-Hasani R; McCall JG; Foshage AM; Bruchas MR
Neuropsychopharmacology; 2013 Nov; 38(12):2484-97. PubMed ID: 23787819
[TBL] [Abstract][Full Text] [Related]
29. Effect of norbinaltorphimine on ∆⁹-tetrahydrocannabinol (THC)-induced taste avoidance in adolescent and adult Sprague-Dawley rats.
Flax SM; Wakeford AG; Cheng K; Rice KC; Riley AL
Psychopharmacology (Berl); 2015 Sep; 232(17):3193-201. PubMed ID: 26025420
[TBL] [Abstract][Full Text] [Related]
30. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
31. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
[TBL] [Abstract][Full Text] [Related]
32. Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration.
Doyon WM; Howard EC; Shippenberg TS; Gonzales RA
Neuropharmacology; 2006 Sep; 51(3):487-96. PubMed ID: 16781738
[TBL] [Abstract][Full Text] [Related]
33. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
Zan GY; Wang Q; Wang YJ; Chen JC; Wu X; Yang CH; Chai JR; Li M; Liu Y; Hu XW; Shu XH; Liu JG
Neuroscience; 2016 Apr; 320():122-8. PubMed ID: 26826330
[TBL] [Abstract][Full Text] [Related]
34. Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
Ise Y; Narita M; Nagase H; Suzuki T
Neurosci Lett; 2002 Apr; 323(2):164-6. PubMed ID: 11950518
[TBL] [Abstract][Full Text] [Related]
35. Role of dorsal hippocampus κ opioid receptors in contextual aversive memory consolidation in rats.
Vanz F; Bicca MA; Linartevichi VF; Giachero M; Bertoglio LJ; Monteiro de Lima TC
Neuropharmacology; 2018 Jun; 135():253-267. PubMed ID: 29499274
[TBL] [Abstract][Full Text] [Related]
36. Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats.
Mori T; Nomura M; Nagase H; Narita M; Suzuki T
Psychopharmacology (Berl); 2002 Apr; 161(1):17-22. PubMed ID: 11967626
[TBL] [Abstract][Full Text] [Related]
37. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
[TBL] [Abstract][Full Text] [Related]
38. kappa-Opioid receptors in the substantia nigra pars reticulata mediate the U-50,488-induced locomotor activity of preweanling rats.
Collins RL; Zavala AR; Nazarian A; McDougall SA
Brain Res Dev Brain Res; 2000 Jan; 119(1):97-103. PubMed ID: 10648876
[TBL] [Abstract][Full Text] [Related]
39. Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on stress and drug-induced reinstatement of nicotine-conditioned place preference in mice.
Jackson KJ; McLaughlin JP; Carroll FI; Damaj MI
Psychopharmacology (Berl); 2013 Apr; 226(4):763-8. PubMed ID: 22526543
[TBL] [Abstract][Full Text] [Related]
40. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence.
Suzuki S; Chuang LF; Doi RH; Bidlack JM; Chuang RY
Int Immunopharmacol; 2001 Sep; 1(9-10):1733-42. PubMed ID: 11562065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
